Oryzon Genomics SA
F:ORN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oryzon Genomics SA
F:ORN
|
ES |
|
GlobalData PLC
LSE:DATA
|
UK |
|
C
|
CBRE Group Inc
XBER:RF6
|
US |
|
C
|
China Petroleum & Chemical Corp
XHAM:CHU
|
CN |
|
E
|
Eiffage SA
F:EF3
|
FR |
|
F
|
FirstEnergy Corp
XMUN:FE7
|
US |
|
V
|
Veolia Environnement SA
DUS:VVD
|
FR |
|
Catalyst Metals Ltd
ASX:CYL
|
AU |
|
P
|
Persol Holdings Co Ltd
F:59R
|
JP |
|
Snowflake Inc.
NYSE:SNOW
|
US |
|
Blackstone Inc
LSE:0HO8
|
US |
Intrinsic Value
The intrinsic value for 
Oryzon Genomics SA (ORN) under the Base Case is hidden
EUR.
Compared with the current market price of 2.68 EUR, the stock appears hidden
.
ORN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ORN usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Oryzon Genomics SA.
The intrinsic value for Oryzon Genomics SA (ORN) under the Base Case is hidden EUR.
Compared with the current market price of 2.68 EUR, the stock appears hidden.
